Search
Search Results
##search.searchResults.foundPlural##
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1379PDF: 782HTML: 409 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2338PDF: 851HTML: 450 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1934PDF: 825HTML: 3689 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4581PDF: 1521HTML: 8537 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
3168PDF: 1084HTML: 272Suppl. Files: 528 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2594PDF: 1744HTML: 534 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1353PDF: 997HTML: 440 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1467PDF: 723HTML: 1186Untitled: 202Untitled: 166Untitled: 156Untitled: 169Untitled: 180 -
FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY
1278PDF: 740HTML: 1257 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2139PDF: 1089HTML: 15736COVER LETTER: 212 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
574PDF: 280HTML: 121 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4378PDF: 1566HTML: 470 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1625PDF: 818HTML: 1529Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 197 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2101PDF: 839HTML: 1226 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3771PDF: 1338HTML: 2167Fig.1: 236Fig. 2: 230 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
762PDF: 482HTML: 6281 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
796PDF: 919PDF Supp. Files: 90HTML: 254
1 - 35 of 35 items







